Accreditation of CBER’s Laboratory Quality System and Reference Materials Production

The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) is seeking to renew the accreditation of its Center for Biologics Evaluation and Research (CBER) Laboratory Quality System and Reference Materials Production. The agency is requesting proposals for a Cost-Plus-Fixed-Fee contract to maintain the laboratory's accreditation to ISO 17025 and ISO 17034 standards. The contract will have a base period of 12 months and three 12-month option periods. Proposals are due by April 19, 2024, at 2:30PM Eastern Time, with a 25-page limit for the technical proposal and a 10-page limit for the business/pricing proposal. The government will use a Quality Assurance Surveillance Plan to monitor the contractor's performance.

This is an unrestricted solicitation without any set-aside designations. The North American Industry Classification System (NAICS) code is 541380, Testing Laboratories. The government has not provided any information about potential incumbents or the anticipated award value. The place of performance is the FDA's CBER facilities.